Oncologic Angiogenesis Imaging in the clinic---how and why.
about
In vivo imaging of therapy-induced anti-cancer immune responses in humans.Immuno-PET imaging of tumor endothelial marker 8 (TEM8)First-In-Human Study Demonstrating Tumor-Angiogenesis by PET/CT Imaging with (68)Ga-NODAGA-THERANOST, a High-Affinity Peptidomimetic for αvβ3 Integrin Receptor TargetingFunctional evaluation of therapeutic response of HCC827 lung cancer to bevacizumab and erlotinib targeted therapy using dynamic contrast-enhanced and diffusion-weighted MRI.
P2860
Oncologic Angiogenesis Imaging in the clinic---how and why.
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Oncologic Angiogenesis Imaging in the clinic---how and why.
@ast
Oncologic Angiogenesis Imaging in the clinic---how and why.
@en
type
label
Oncologic Angiogenesis Imaging in the clinic---how and why.
@ast
Oncologic Angiogenesis Imaging in the clinic---how and why.
@en
prefLabel
Oncologic Angiogenesis Imaging in the clinic---how and why.
@ast
Oncologic Angiogenesis Imaging in the clinic---how and why.
@en
P2860
P356
P1433
P1476
Oncologic Angiogenesis Imaging in the clinic---how and why
@en
P2093
Liza Lindenberg
Peter L Choyke
P2860
P304
P356
10.2217/IIM.11.31
P577
2011-09-01T00:00:00Z